HLL Lifecare’s ethinylestradiol/levonorgestrel prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Past News
Lupin’s dolutegravir/lamivudine/tenofovir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Aabcavir (sulfate) (WHOAPI-377) manufactured by Jiangsu Weiqida Pharmaceutical Co Ltd, has been prequalified by the WHO Prequalific
First delamanid prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Desano’s efavirenz/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First paediatric linezolid prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Independent Performance Evaluation for SARS-COV-2 Antigen RDTS
IVD
WHO PQT in collaboration with PATH and FIND will perform an independent performance evaluation to generate additional performance data for RDTs that are undergoing EUL assessment and for those that
Macleods’ Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) dispersible tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
The following APIs were added:
New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C published
M
New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C.
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-439) manufactured by Emcure Pharmaceuticals Ltd, has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) u
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Protionamide (WHOAPI-424) manufactured by Micro Labs Ltd, has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification proc
First Carbetocin Active Pharmaceutical Ingredient (API) Prequalified
M
Carbetocin (WHOAPI-423) manufactured by Hemmo Pharmaceuticals Pvt.
Cipla’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Revised Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) Published
M
The EOI for artesunate/pyronaridine products is being revised to bring it in line with currently available artesunate/pyronaridine comparator products.
First molnupiravir active pharmaceutical ingredient (API) prequalified
M
Molnupiravir (WHOAPI-451) manufactured by Divi’s Laboratories Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalif